Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Iacobone, Floriana"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Moschella, Federica, Buccione, Carla, Ruspantini, Irene, Castiello, Luciano, Gonzalez, Andrea Rozo, Iacobone, Floriana, Ferraresi, Virginia, Palermo, Belinda, Nisticò, Paola, Belardelli, Filippo, Proietti, Enrico, Macchia, Iole, Urbani, Francesca
Publikováno v:
Frontiers in Oncology; 2023, p1-16, 16p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ilaria Vanni, Floriana Iacobone, Claudia D’Agostino, Matteo Giovannelli, Laura Pirisinu, Hermann Clemens Altmeppen, Joaquin Castilla, Juan Maria Torres, Umberto Agrimi, Romolo Nonno
15 Pág.
The prion protein (PrPC) is subjected to several conserved endoproteolytic events producing bioactive fragments that are of increasing interest for their physiological functions and their implication in the pathogenesis of prion disease
The prion protein (PrPC) is subjected to several conserved endoproteolytic events producing bioactive fragments that are of increasing interest for their physiological functions and their implication in the pathogenesis of prion disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::163fbd1ee22fa08589f2a177d1ecc50d
https://api.elsevier.com/content/abstract/scopus_id/85146425636
https://api.elsevier.com/content/abstract/scopus_id/85146425636
Autor:
Macchia I; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità (ISS), Rome 00161, Italy., La Sorsa V; Research Coordination and Support Service, CoRI, ISS, Rome 00161, Italy., Ruspantini I; Core Facilities, ISS, Rome 00161, Italy., Sanchez M; Core Facilities, ISS, Rome 00161, Italy., Tirelli V; Core Facilities, ISS, Rome 00161, Italy., Carollo M; Core Facilities, ISS, Rome 00161, Italy., Fedele G; Department of Infectious Diseases, ISS, Rome 00161, Italy., Leone P; Department of Infectious Diseases, ISS, Rome 00161, Italy., Schiavoni G; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità (ISS), Rome 00161, Italy., Buccione C; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità (ISS), Rome 00161, Italy., Rizza P; Center for Gender-Specific Medicine, ISS, Rome 00161, Italy., Nisticò P; Unit of Tumor Immunology and Immunotherapy, IRCCS Regina Elena National Cancer Institute (IRE), Rome 00128, Italy., Palermo B; Unit of Tumor Immunology and Immunotherapy, IRCCS Regina Elena National Cancer Institute (IRE), Rome 00128, Italy., Morrone S; Department of Experimental Medicine, Sapienza University of Rome (SUR), 00185, Italy., Stabile H; Department of Molecular Medicine, SUR, Rome 00185, Italy., Rughetti A; Department of Experimental Medicine, Sapienza University of Rome (SUR), 00185, Italy., Nuti M; Department of Experimental Medicine, Sapienza University of Rome (SUR), 00185, Italy., Zizzari IG; Department of Experimental Medicine, Sapienza University of Rome (SUR), 00185, Italy., Fionda C; Department of Molecular Medicine, SUR, Rome 00185, Italy., Maggio R; Clinical Research, Imperial College, London W12 ONN, UK., Capuano C; Department of Experimental Medicine, Sapienza University of Rome (SUR), 00185, Italy., Quintarelli C; Onco-Hematology Department, IRCCS Bambino Gesù Children's Hospital (OPBG), Rome 00165, Italy., Sinibaldi M; Onco-Hematology Department, IRCCS Bambino Gesù Children's Hospital (OPBG), Rome 00165, Italy., Agrati C; Cellular Immunology Laboratory, IRCCS National Institute for Infectious Diseases 'L. Spallanzani' (INMI), Rome 00149, Italy., Casetti R; Cellular Immunology Laboratory, IRCCS National Institute for Infectious Diseases 'L. Spallanzani' (INMI), Rome 00149, Italy., Rozo Gonzalez A; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità (ISS), Rome 00161, Italy., Iacobone F; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità (ISS), Rome 00161, Italy., Gismondi A; Department of Molecular Medicine, SUR, Rome 00185, Italy., Belardelli F; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità (ISS), Rome 00161, Italy.; Institute of Translational Pharmacology, National Research Council, Rome 00185, Italy., Biffoni M; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità (ISS), Rome 00161, Italy., Urbani F; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità (ISS), Rome 00161, Italy.; Medical Biotechnology and Translational Medicine PhD School, Tor Vergata University, Rome 00133, Italy.
Publikováno v:
Journal of immunology research [J Immunol Res] 2020 Aug 10; Vol. 2020, pp. 2698258. Date of Electronic Publication: 2020 Aug 10 (Print Publication: 2020).